Mirae Asset Global Etfs Holdings Ltd. Exelixis, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $39.6 Billion
- Q2 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Exelixis, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 28,942 shares of EXEL stock, worth $1.05 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,942Holding current value
$1.05 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding EXEL
# of Institutions
468Shares Held
240MCall Options Held
1.87MPut Options Held
1.12M-
Black Rock Inc. New York, NY33.5MShares$1.21 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.7MShares$1.07 Billion0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA27.1MShares$981 Million2.95% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.2MShares$549 Million0.6% of portfolio
-
State Street Corp Boston, MA12.6MShares$456 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11.6B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...